NEWS AND EVENTS
October 18, 2017 to January 31, 2018 | CPRIT Multi-Investigator Research Awards (MIRA) - Funding Opportunities
With a dedicated, experienced team conveniently and centrally located in the Texas Medical Center, CTX CRO Services staff are available to lend support to your multi-site clinical trial, projects and grant submissions, and/or planned response to CPRIT MIRA opportunities. The key is to contact CTX before you make your grant or RFA submission such that a line item for service fee can be added to your budget to cover the costs of CTX CRO services.
November 17, 2017 | University of Texas Health Science Center at Houston
CTX will host a Clinical Research Navigator meeting which will bring together CTX dedicated clinical operations personnel from each of the 5 CTSA campuses. The meeting will focus on discussions to better streamline clinical trial operational processes and improve efficiencies at UT campuses, to provide physician-investigators and industry sponsors with a seamless clinical trial experience. The meeting will be held on November 17, 2017 at The University of Texas Health Science Center at Houston, located in the heart of the Texas Medical Center, at 6410 Fannin Street, Suite 1100 from 9:00 a.m. to 4:00 p.m. More details to follow soon.
May 21-24, 2018 | Moody Gardens Hotel, Galveston Texas
UTMB will host the 2018 Science of Team Science (ScITS) conference. SciTS is a rapidly growing cross-disciplinary field of study that aims to build an evidence-base and to develop translational applications to help maximize the efficiency and effectiveness of team-based research. More information coming soon.
Clinical Trials Xpress (CTX) is a UT System initiative launched in 2015 with support and seed funding from its Board of Regents, CTX represents an unmatched resource to support multistie clinical and translational research in Texas.
A single point-of-entry for industry sponsors and physician investigators to access streamlined, efficient administrative processes, dedicated central office resources and accelerated activation timelines to conduct their multi-site clinical trials in Texas.